Article Name Clinical Trials and Research
The outpatient procedures were performed as part of an ongoing FDA IDE clinical trial
17th September, 2025
Medtech firm unveils Axana®, a 50kg, AI-enhanced, portable MRI device that cuts stroke diagnosis time by over 90%—unlocking lifesaving treatment in the golden hour and opening an $8.9bn global market opportunity.
16th September, 2025
The Prinses Máxima Centre is the largest pediatric cancer centre in Europe, dedicated to integrating care and research to improve outcomes for children with cancer
11th September, 2025
Study will begin enrollment in Q1 2026 in the US and UK and leverage the BIOFIRE® SPOTFIRE® point-of-care diagnostics platform at U.S. sites
10th September, 2025
Improves p-wave signal detection up to 160%, helping clinicians identify atrial abnormalities to prevent future adverse cardiac events
10th September, 2025
Robust 24-month complete response (CR) rate of 41.8 per cent observed for cretostimogene monotherapy in patients with high-risk non-muscle invasive bladder cancer (NMIBC) who are unresponsive to Bacillus Calmette Guerin (BCG) treatment
08th September, 2025
The validation was carried out under ISO 11137 by an international medical device accredited organisation
04th September, 2025
Sleep Institute publishes original research, expert perspectives, and real-world data to support earlier and more accurate diagnosis and guide more informed clinical, policy
04th September, 2025
Alliance integrates Siemens’ digital pathology solutions with Evident’s Pramana platform to modernize diagnostics, unify clinical workflows, and advance AI-driven personalised healthcare in Germany.
04th September, 2025
The technology is compatible with all PTFE grafts and was studied extensively in the company's pivotal clinical trial
02nd September, 2025
Revenue up 5.8 per cent to HK$876.5 million, Profit up 3.8 per cent to HK$163.4 million
01st September, 2025
The RAD Temp ensures uninterrupted cancer treatment in Northeast Texas as TRMC upgrades its vault and linear accelerator for more precise, advanced care.
01st September, 2025
Lumipulse pTau-217/Beta Amyloid 42 ratio now available nationwide through Labcorp
19th August, 2025
Quarterly rehab program now welcomes Parkinson’s patients, offering intensive therapy with NeuFit’s NEUBIE device.
14th August, 2025
Trial to assess Calibreye™ Titratable Glaucoma Therapy™ Surgical System in refractory glaucoma patients
13th August, 2025
CEO Lawrence Florin discusses how human-relevant organ-on-a-chip systems and continuously updated digital twins are improving translational accuracy, reducing reliance on animal testing, and opening new frontiers in precision medicine.
13th August, 2025
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer